Viewing Study NCT05021120


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2026-05-21 @ 8:25 PM
Study NCT ID: NCT05021120
Status: COMPLETED
Last Update Posted: 2025-12-04
First Post: 2021-08-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK127 in Combination With AK104 in Advanced and Metastatic Solid Tumours
Sponsor: Akesobio Australia Pty Ltd
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: AK127-101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators